Patent Assignment
Reel/Frame 025456/0172
Confirmatory Grant of Security Interest in United States Patents (Exclusively Licensed Patents)
Recorded: 2010-12-09
Pages: 13
Assignor
ENDO PHARMACEUTICALS INC.
Executed: 2010-11-30
Assignee
JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
10 SOUTH DEARBORN, CHICAGO, ILLINOIS, 60603
Covered Properties
(77)
Methods, Compositions, and Kits for Treating Pain and Pruritis
PCT:
PCT/US2009/001541 ↗
Process for the Preparation of Azoniaspironortropanol Esters
Patent:
4,855,422 →
Application:
06/945,488 →
Azoniaspironortropanol Esters as Asthma Therapeutics and Broncholytics
Patent:
4,780,476 →
Application:
06/945,773 →
Method for Treating Pain Associated with Herpes-Zoster and Post- Herpetic Neuralgia
Patent:
5,601,838 →
Application:
07/526,771 →
Diphenyl Compounds Which Inhibit Arachidonic Acid Metabolism, and Their Use in Pharmaceutical Compositions
Patent:
5,185,377 →
Application:
07/754,788 →
Use of Tetrahydrocarbazone Derivatives as 5HT1 Receptor Agonists
Patent:
5,464,864 →
Application:
08/167,846 →
Method for Treating Nerve Injury Pain Associated with Shingles (Herpes-Zoster and Post-Herpetic Neuralgia) by Topical Application of Lidocaine
Patent:
5,411,738 →
Application:
08/198,223 →
Sustained-Release Drug Delivery System
Patent:
5,484,608 →
Application:
08/218,757 →
Non-Occulusive Adhesive Patch for Applying Medication to the Skin
Patent:
5,536,263 →
Application:
08/219,982 →
Shoe Sole Including a Peripherally-Disposed Cushioning Bladder
Patent:
5,595,004 →
Application:
08/220,032 →
Multilamellar Drug Delivery Systems
Patent:
5,447,729 →
Application:
08/224,340 →
Recurrent Aphthous Ulcer Treatment Method
Patent:
5,500,448 →
Application:
08/241,827 →
Novel Isoindolinone Derivative, Preparation Thereof, and Pharmaceutical Compositions Containing Same
Patent:
5,494,915 →
Application:
08/286,294 →
Medicaments
Patent:
5,637,611 →
Application:
08/442,719 →
Medicaments 1,2,3,4-Tetrahydecarbazoles and 5-Ht,Agonist Use Thereof
Patent:
5,827,871 →
Application:
08/442,720 →
Process of Preparing Enantiomers of Carbazole Derivatives
Patent:
5,618,947 →
Application:
08/446,655 →
Process for Preparing an Enantiomer of Carbazole Derivative
Patent:
5,618,948 →
Application:
08/451,846 →
Enantiomers of Carbazole Derivatives as 5-HT1-Like Agonists
Patent:
5,616,603 →
Application:
08/451,898 →
Solubilization of Pharmaceutical Substances in an Organic Solvent and Preparation of Pharmaceutical Powders Using the Same
Patent:
5,770,559 →
Application:
08/473,008 →
Novel Isoindolinone Derivative, Preparation Thereof and Pharmaceutical Compositions Containing Same
Patent:
5,599,936 →
Application:
08/476,749 →
Method for Treating Nerve Injury Pain Associated with Shingles (Herpes-Zoster and Post-Herpetic Neuralgia) by Topical Application of Lidocaine
Patent:
5,589,180 →
Application:
08/611,168 →
Adhesive Patch for Applying Analgesic Medication to the Skin
Patent:
5,741,510 →
Application:
08/629,191 →
Temperature Sensitive Gel for Sustained Delivery of Protein Drugs
Patent:
5,861,174 →
Application:
08/679,199 →
Method and Composition for Topical Therapy of Back Pain and Muscle Tension
Patent:
5,776,952 →
Application:
08/682,352 →
Enantiomer of Carbazole Derivative as 5-HT1-Like Agonists
Patent:
5,962,501 →
Application:
08/770,926 →
Method for Treating Nerve Injury Pain Assocaited with Shingles
Patent:
5,709,869 →
Application:
08/773,529 →
Process for Preparing Enantiomers of Carbazole Derivatives as 5-HT1- Like Agonists
Patent:
5,917,054 →
Application:
08/781,990 →
Emulsified Drug Delivery System
Patent:
5,897,876 →
Application:
08/879,994 →
Method of Forming Adhesive Patch for Applying Medication to the Skin
Patent:
6,096,333 →
Application:
08/947,089 →
Solubilization of Pharmaceutical Substances in an Organic Solvent and Preparation of Pharmaceutical Powders Using the Same
Patent:
5,981,474 →
Application:
09/098,791 →
Bacterial Cell Complex Composition and Method of Use
Patent:
6,326,357 →
Application:
09/129,312 →
Composition and Method for the Treatment of Bladder Cancer
Patent:
6,329,347 →
Application:
09/129,313 →
Solid Solution Beadlet
Penetration Enhancing and Irritation Reducing Systems
Patent:
6,319,913 →
Application:
09/189,090 →
Method of Forming Adhesive Patch for Applying Medication to the Skin
Patent:
6,096,334 →
Application:
09/211,222 →
Temperature Sensitive Gel for Sustained Delivery of Protein Drugs
Patent:
6,482,435 →
Application:
09/232,288 →
Solid Oral Dosage Form
Patent:
6,793,934 →
Application:
09/457,248 →
Intrademal-Penetration Agents for Topical Local Anesthetic Administration
Patent:
6,455,066 →
Application:
09/523,652 →
6-Dimethylaminomethyl-1-pheny-cyclohexane compounds as pharmaceutical active ingredients
Patent:
37,355 →
Application:
09/539,528 →
Method of forming adhesive patch for applying medication to the skin
Patent:
6,361,790 →
Application:
09/629,783 →
Process for the production of R-(+)-6-carboxamido-3-N-methylamino-1,2,3,4-tetrahydrocarbazole
Patent:
6,359,146 →
Application:
09/689,661 →
Chemotherapeutic Composition and Method
Patent:
6,809,081 →
Application:
09/857,332 →
Method for the Treatment of Inflammation
Patent:
6,890,911 →
Application:
09/857,333 →
System for Osmotic Delivery of Pharmaceutically Active Agents
Sustained-Release Composition Including Amorphous Polymer
Composition and Method for Inducing Apoptosis in Prostate Cancer Cells
Patent:
6,794,368 →
Application:
09/937,643 →
Penetration Enhancing and Irritation Reducing Systems
Hyaluronic Acid in the Treatment of Cancer
Intradermal-Penetration Agents for Topical Local Anesthetic Administration
Method for the Enzymatic Resolution of the Racemates of Aminomethyl-Aryl-Cyclohexanol Derivatives
Penetration Enhancing and Irritation Reducing Systems
Dosage Form That Is Safeguarded from Abuse
Application:
10/567,594 →
Publication:
US 2007/0183980
Abuse-proofed dosage form
Methods and Pharmaceutical Compositions for Reliable Achievement of Acceptable Serum Testosterone Levels
Combination of selected opioids with muscarine antagonists for treating urinary incontinence
Application:
10/803,187 →
Publication:
US 2004/0242617
Process for the production of an abuse-proofed solid dosage form
Application:
10/890,703 →
Publication:
US 2005/0236741
Process for Production of an Abuse-Proofed Solid Dosage Form
Abuse-proofed oral dosage form
Application:
10/890,763 →
Publication:
US 2006/0002860
Compositions and Methods for the Treatment of Urinary Incontinence
Combination of Selected Analgesics and Cox-Ii Inhibitors
Pharmaceutical composition containing 6-dimethylaminomethyl-1-(3-methoxyphenyl)-cyclohexane-1,3-diol with delayed active ingredient release
Application:
11/334,344 →
Publication:
US 2006/0121113
Process for the production of an abuse-proofed dosage form
Application:
11/348,276 →
Publication:
US 2006/0188447
Crush resistant delayed-release dosage forms
Application:
11/348,295 →
Publication:
US 2006/0193914
Abuse-proofed dosage form
Application:
11/349,537 →
Publication:
US 2006/0193782
Abuse-Proofed Dosage Form
Phosphate salts of 6-dimethylaminomethyl-1-(3-methoxyphenyl)-1,3-dihydroxy-cyclohexane compounds
Application:
11/361,954 →
Publication:
US 2006/0211887
Abuse-Proofed Dosage Form
Application:
11/462,216 →
Publication:
US 2007/0048228
Process for the production of an abuse-proofed dosage form
Application:
11/471,438 →
Publication:
US 2007/0003616
Method of Inhibiting Inflammatory Pain
Use of Axomadol for Treatment of Arthrosis Pain
Application:
12/118,231 →
Publication:
US 2008/0306161
Abuse-Proofed Dosage Form
Application:
12/140,444 →
Publication:
US 2008/0247959
Abuse-Proofed Oral Dosage Form
Application:
12/140,470 →
Publication:
US 2008/0248113
Process for the Production of an Abuse-Proofed Solid Dosage Form
Process for the Production of an Abuse-Proofed Dosage Form
Application:
12/140,609 →
Publication:
US 2008/0311197
Abuse-Proof Dosage Form
Process for the Production of an Abuse-Proofed Dosage Form
Application:
12/140,718 →
Publication:
US 2009/0005408
Methods, Compositions, and Kits for Treating Pain and Pruritis
Application:
12/515,429 →
Publication:
US 2010/0099772
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Merger
Mar 19, 1990
From: DR. MADAUS GMBH & CO. A LIMITED LIABILITY COMPANY
To: MADAUS AKTIENGESELLSCHAFT
Reel/Frame 005261/0779 →
Assignment of Assignors Interest.
Oct 26, 1992
From: SCHEWE, TANKRED; LUTHER, HELMUT; JORDANOV, DENTSCHO
To: CIBA-GEIGY CORPORATION, A CORP. OF NEW YORK
Reel/Frame 006309/0383 →
Assignment of Assignor's Interest
Dec 23, 1993
From: KING, FRANCIS DAVID; GASTER, LARAMIE MARY; KAUMANN, ALBERTO JULIO; YOUNG, RODNEY CHRISTOPHER
To: SMITHKLINE BEECHAM P.L.C.
Reel/Frame 007076/0205 →
Assignment of Assignor's Interest
Mar 28, 1994
From: RUDNIC, EDWARD M.; MCCARTY, JOHN A.; BELENDUIK, GEORGE W.
To: PHARMAVENE, INC.
Reel/Frame 006944/0857 →
Assignment of Assignor's Interest
Mar 30, 1994
From: ROLF, DAVID; URMANN, ELISABETH K. SJOBLOM
To: LECTEC CORPORATION
Reel/Frame 006944/0606 →
Assignment of Assignor's Interest
Apr 7, 1994
From: BELEDUIK, GEORGE W.; RUDNIC, EDWARD M.; MCCARTY, JOHN A.
To: PHARMAVENE, INC.
Reel/Frame 006948/0946 →
Assignment of Assignor's Interest
May 16, 1994
From: HIND, HARRY
To: HIND HEALTH CARE, INC.
Reel/Frame 007006/0216 →
Assignment of Assignor's Interest
Jun 28, 1994
From: LYDEN, ROBERT M.; AVENI, MICHAEL A.
To: NIKE, INC.
Reel/Frame 007048/0264 →
Assignment of Assignor's Interest
Sep 6, 1994
From: CUMMINS, DIANE; VAN DER OUDERAA, FRANCISCUS JOHANNES G.; TRAUDT, MICHAEL DAVID
To: CHESEBROUGH-POND'S USA CO., DIVISION OF CONOPCO, INC.
Reel/Frame 007118/0430 →
Assignment of Assignor's Interest
Sep 19, 1994
From: BARREAU, MICHEL; CHEVE, MICHEL; DUBROEUCQ, MARIE-CHRISTINE; DUTRUC-ROSSET, GILLES
To: RHONE-POULENC RORER S.A.
Reel/Frame 007145/0136 →
Merger
Mar 30, 1995
From: APPLIED BIOSYSTEMS, INC.
To: PERKIN ELMER CORPORATION, THE
Reel/Frame 007408/0429 →
Assignment of Assignor's Interest
Jun 6, 1995
From: MANNING, MARK C.
To: REGENTS OF THE UNIVERSITY OF COLORADO, THE
Reel/Frame 007546/0801 →
Assignment of Assignor's Interest
Jun 6, 1995
From: SHEFTER, ELI
To: COLORADO, THE UNIVERSITY OF, REGENTS OF, THE
Reel/Frame 007546/0805 →
Assignment of Assignor's Interest
Jun 6, 1995
From: RANDOLPH, THEODORE W.; FALK, RICHARD F., III
To: REGENTS OF THE UNIVERSITY OF COLORADO, THE
Reel/Frame 007546/0813 →
Assignment of Assignor's Interest
Jul 20, 1995
From: BORRETT, GARY THOMAS; KITTERINGHAM, JOHN; PORTER, RODERICK ALAN; SHIPTON, MARK RALPH
To: SMITHKLINE BEECHAM P.L.C.
Reel/Frame 007566/0567 →
Assignment of Assignor's Interest
Jul 24, 1995
From: BORRETT, GARY THOMAS; KITTERINGHAM, JOHN; PORTER, RODERICK ALAN; SHIPTON, MARK RALPH
To: SMITHKLINE BEECHAM P.L.C.
Reel/Frame 007557/0988 →
Assignment of Assignor's Interest
Jul 24, 1995
From: BORRETT, GARY THOMAS; KITTERINGHAM, JOHN; PORTER, RODERICK ALAN; SHIPTON, MARK RALPH
To: SMITHKLINE BEECHAM P.L.C.
Reel/Frame 007559/0024 →
Assignment of Assignor's Interest
Apr 8, 1996
From: ROLF, DAVID; URMANN, ELISABETH K. SJOBLOM
To: LECTEC CORPORATION
Reel/Frame 007964/0473 →
Assignment of Assignor's Interest
Jul 12, 1996
From: STRATTON, LEWIS P.; CARPENTER, JOHN F.; MANNING, MARK C.
To: UNIVERSITY TECHNOLOGY CORPORATION
Reel/Frame 008097/0261 →
Assignment of Assignor's Interest
Mar 17, 1997
From: CIBA-GEIGY CORPORATION
To: CIBA SPECIALTY CHEMICALS CORPORATION
Reel/Frame 008412/0471 →
Merger and Change of Name
Dec 8, 1997
From: PHARMAVENE, INC.
To: SHIRE LABORATORIES, INC.
Reel/Frame 008842/0228 →
Merger
Dec 8, 1997
From: PHARMAVENE, INC.
To: SHIRE LABORATORIES, INC.
Reel/Frame 008842/0231 →
Assignment of Assignor's Interest
Mar 23, 1998
From: LIEDTKE, RAINER K.
To: AMERICAN PHARMED LABS, INC.
Reel/Frame 009050/0464 →
Security Agreement
Feb 8, 2000
From: SHIRE LABORATORIES INC.
To: DLJ CAPITAL FUNDING, INC. AS ADMINISTRATIVE AGENT
Reel/Frame 010572/0042 →
Security Interest
May 15, 2000
From: LECTEC CORPORATION
To: WELLS FARGO BUSINESS CREDIT, INC.
Reel/Frame 010822/0294 →